文献速递湿疹皮炎与荨麻疹

角质层神经酰胺谱可可靠指示特应性皮炎的缓解与潜在复发

Stratum Corneum Ceramide Profiles Provide Reliable Indicators of Remission and Potential Flares in Atopic Dermatitis.
PubMed 文献 · J Invest Dermatol · 2022-07-21

本研究比较特应性皮炎缓解期后续复发组与未复发组之间FLG突变频率及角质层11类神经酰胺的水平和碳链长度差异。结果显示两组FLG突变频率无差异,而含非羟基脂肪酸与二氢鞘氨醇、鞘氨醇及6-羟基鞘氨醇的神经酰胺碳链长度在复发组更短,提示缓解期角质层神经酰胺谱是预测特应性皮炎缓解或后续复发的潜在生物标志物。

要点

  • 特应性皮炎缓解期后续复发组与未复发组的FLG突变频率无差异。
  • 含非羟基脂肪酸与二氢鞘氨醇、鞘氨醇及6-羟基鞘氨醇的神经酰胺碳链长度在复发组较未复发组更短。
  • 缓解期角质层神经酰胺谱是预测特应性皮炎缓解或后续复发的潜在生物标志物。

核心结论

  • 特应性皮炎缓解期角质层神经酰胺谱是预测显著缓解或后续复发的潜在生物标志物。
  • FLG突变频率在后续复发组与未复发组之间无差异。

研究设计与样本

  • 本研究比较特应性皮炎缓解期后续复发(+)组与未复发(‒)组之间FLG突变频率及角质层11类神经酰胺的水平和碳链长度差异。

主要发现

  • 后续复发(+)组与未复发(‒)组的FLG突变频率无差异。
  • 含非羟基脂肪酸与二氢鞘氨醇、非羟基脂肪酸与鞘氨醇、非羟基脂肪酸与6-羟基鞘氨醇的神经酰胺碳链长度在复发组较未复发组更短。

关键数值与推荐

  • 检测角质层11类神经酰胺的水平和碳链长度,包括含非羟基脂肪酸与二氢鞘氨醇、非羟基脂肪酸与鞘氨醇、非羟基脂肪酸与6-羟基鞘氨醇、非羟基脂肪酸与植物鞘氨醇、α-羟基脂肪酸与二氢鞘氨醇、α-羟基脂肪酸与鞘氨醇、α-羟基脂肪酸与6-羟基鞘氨醇、α-羟基脂肪酸与植物鞘氨醇、酯键脂肪酸与ω-羟基脂肪酸及鞘氨醇、酯键脂肪酸与ω-羟基脂肪酸及6-羟基鞘氨醇、酯键脂肪酸与ω-羟基脂肪酸及植物鞘氨醇的神经酰胺。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atopic dermatitis (AD) is a chronic inflammatory skin disease. Prevention of exacerbation of AD is a crucial issue for all physicians. However, exacerbation of AD often is seen during reduction of AD treatment, even with appropriate follow-up by tapered topical corticosteroids and daily topical moisturizers, indicating the need for good indicators of AD remission. We hypothesized that the presence of mutations in FLG or the stratum corneum ceramide profile on AD remission phase may predict the ease of AD exacerbation. This study examined the differences in the frequency of FLG mutations or stratum corneum ceramide profiles (stratum corneum levels and carbon chain length for 11 ceramide classes [ceramides containing nonhydroxy fatty acids and dihydrosphingosines; nonhydroxy fatty acids and sphingosines; nonhydroxy fatty acids and 6-hydroxysphingosines; nonhydroxy fatty acids and phytosphingosines; a-hydroxy fatty acids and dihydrosphingosines; a-hydroxy fatty acids and sphingosines; a-hydroxy fatty acids and 6-hydroxysphingosines; a-hydroxy fatty acids and phytosphingosines; ester-linked fatty acids, o-hydroxy fatty acids, and sphingosines; ester-linked fatty acids, o-hydroxy fatty acids, and 6-hydroxysphingosines; and ester-linked fatty acids, o-hydroxy fatty acids, and phytosphingosines]) at AD remission phase between the two AD study groups: subsequent exacerbation (‒) and (+) of AD. The frequency of FLG mutations did not differ between the study groups. On the other hand, the carbon chain lengths of ceramides containing nonhydroxy fatty acids and dihydrosphingosines, nonhydroxy fatty acids and sphingosines, and nonhydroxy fatty acids and 6-hydroxysphingosines were shorter in the exacerbated AD group than in the maintained-AD group. Thus, the stratum corneum ceramide profile at the remission phase of AD is a potential biomarker, predicting the likelihood of substantial AD remission or subsequent AD exacerbation.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Sho Y, Sakai T, Sato T, et al. Stratum Corneum Ceramide Profiles Provide Reliable Indicators of Remission and Potential Flares in Atopic Dermatitis. J Invest Dermatol. 2022. PMID: 35870561. doi:10.1016/j.jid.2022.06.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。